Profil bibliographique

Peter Akhideno

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

24Publications signalées

442Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Viral Infections and Outbreaks ResearchDisaster Response and ManagementPharmaceutical Practices and Patient OutcomesHepatitis B Virus StudiesFolate and B Vitamins Research

Publications récentes

Accès ouvert 2025 article

Safety and tolerability of Favipiravir compared to Ribavirin for the treatment of Lassa fever: A randomized controlled open-label phase II clinical trial

Cyril Emerer, Kevin Okwaraeke, Meike Pahlmann, Christine J. Kleist et autres

1 citationJournal of Interventional Epidemiology and Public Health

Accès ouvert 2025 article

Electrocardiographic alterations in patients treated for acute Lassa Fever: Description of results from a phase II clinical trial in Nigeria

Cyril Erameh, Oladele Oluwafemi Ayodeji, Augusto Meneguim, Kevin Okwaraeke et autres

4 citationsJournal of Infection and Public Health

Accès ouvert 2024 article

Virus Load Kinetics in Lassa Fever Patients Treated With Ribavirin: A Retrospective Cohort Study From Southern Nigeria

Ephraim Ogbaini-Emovon, George O. Akpede, Sylvanus Okogbenin, Emmanuel Friday Osagiede et autres

10 citationsOpen Forum Infectious Diseases

Accès ouvert 2023 conference-abstract

OA-652 Safety and tolerability of favipiravir for the treatment of Lassa fever: a randomized controlled open label phase II clinical trial

Mirjam Groger, Kevin Okwaraeke, Peter Akhideno, Meike Pahlmann et autres

2 citations

Accès ouvert 2023 article

Lassa Fever Infection among Healthcare Workers during the 2018 Outbreak in Nigeria

Ephraim Ogbaini-Emovon, Francis Osemhoahu Erah, Emmanuel Friday Osagiede, C. Nnadi et autres

3 citationsInternational Journal of Occupational Safety and Health

2023 article

An Evaluation of the Knowledge and Utilization of the Essential Medicines List among Health Professionals in Six Tertiary Institutions in Nigeria.

Stephen A. Ayinbuomwan, Abimbola O. Opadeyi, JO Ohaju-Obodo, Peter Akhideno et autres

1 citationPubMed

Accès ouvert 2023 article

The Unusual Finding of Peripheral Lymphadenopathy Among Confirmed Lassa Fever Patients in Nigeria

Sampson Omagbemi Owhin, C Abejegah, Lanre O Olatunde, Nelson A Adedosu et autres

0 citationsFuture Science OA

Accès ouvert 2022 article

Two Cases of Lassa Fever Successfully Treated with Ribavirin and Adjunct Dexamethasone for Concomitant Infections

Sylvanus Okogbenin, Cyril Erameh, Joseph Okoeguale, Osahogie Isaac Edeawe et autres

8 citationsEmerging infectious diseases

Accès ouvert 2022 article

Pharmacokinetics of Ribavirin in the Treatment of Lassa Fever: An Observational Clinical Study at the Irrua Specialist Teaching Hospital, Edo State, Nigeria

Mirjam Groger, Peter Akhideno, Christine J. Kleist, Oluwasola Babatunde et autres

16 citationsClinical Infectious Diseases

Accès ouvert 2022 article

Psychiatric manifestations and associated risk factors among hospitalised patients with COVID-19 in Edo State, Nigeria: a cross-sectional study

Esther Okogbenin, Omonefe Joy Seb‐Akahomen, Osahogie Isaac Edeawe, Mary Ehimigbai et autres

7 citationsBMJ Open

Accès ouvert 2021 preprint

Psychiatric Manifestations and Associated Risk Factors among Hospitalized Patients with COVID-19 in Edo State, Nigeria

Esther Okogbenin, Omonefe Joy Seb‐Akahomen, Osahogie Isaac Edeawe, Mary Ehimigbai et autres

0 citationsmedRxiv

Accès ouvert 2020 article

Association of Hypoalbuminemia and Reversal of Albumin-to-Globulin Ratio with Morbidity Outcome among Hospitalized Lassa Fever Infected Patients at a Dedicated Treatment Center in Ondo state, South-Western Nigeria

Sampson Omagbemi Owhin, Chukwuyem Abejegah, Olumuyiwa John Fasipe, Abiodun Tolani Abidoye et autres

5 citationsFuture Science OA

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.